Osteocalcin Promotes β-Cell Proliferation During Development and Adulthood Through Gprc6a

Jianwen Wei; Hanna, Timothy; Suda, Nina; Karsenty, Gerard; Ducy, Patricia
March 2014
Diabetes;Mar2014, Vol. 63 Issue 3, p1021
Academic Journal
Expanding β-cell mass through β-cell proliferation is considered a potential therapeutic approach to treat β-cell failure in diabetic patients. A necessary step toward achieving this goal is to identify signaling pathways that regulate β-cell proliferation in vivo. Here we show that osteocalcin, a bone-derived hormone, regulates β-cell replication in a cyclin D1--dependent manner by signaling through the Gprc6a receptor expressed in these cells. Accordingly, mice lacking Gprc6a in the β-cell lineage only are glucose intolerant due to an impaired ability to produce insulin. Remarkably, this regulation occurs during both the perinatal peak of β-cell proliferation and in adulthood. Hence, the loss of osteocalcin/Gprc6a signaling has a profound effect on β-cell mass accrual during late pancreas morphogenesis. This study extends the endocrine role of osteocalcin to the developmental period and establishes osteocalcin/Gprc6a signaling as a major regulator of β-cell endowment that can become a potential target for β-cell proliferative therapies.


Related Articles

  • Metabolic disorders: Betatrophin boosts β-cells. Crunkhorn, Sarah // Nature Reviews Drug Discovery;Jul2013, Vol. 12 Issue 7, p504 

    The article discusses research being done on a novel liver-secreted hormone called betatrophin. It references a study by P. Yi et al published in a 2013 issue of "Cell."According to the study, an adult mice infused with a 43-amino-acid peptide showed glucose intolerance, insulin resistance,...

  • Postnatal β-Cell Proliferation and Mass Expansion Is Dependent on the Transcription Factor Nkx6.1. Taylor, Brandon L.; Benthuysen, Jacqueline; Sander, Maike // Diabetes;Mar2015, Vol. 64 Issue 3, p897 

    All forms of diabetes are characterized by a loss of functional β-cell mass, and strategies for expanding β-cell mass could have significant therapeutic benefit. We have recently identified the transcription factor Nkx6.1 as an essential maintenance factor of the functional β-cell...

  • Transgenic Overexpression of Active Calcineurin in β-Cells Results in Decreased β-Cell Mass and Hyperglycemia. Bernal-Mizrachi, Ernesto; Cras-Méneur, Corentin; Ye, Bo Ra; Johnson, James D.; Permutt, M. Alan // PLoS ONE;2010, Vol. 5 Issue 8, p1 

    Background: Glucose modulates β-cell mass and function through an initial depolarization and Ca2+ influx, which then triggers a number of growth regulating signaling pathways. One of the most important downstream effectors in Ca2+ signaling is the calcium/Calmodulin activated serine threonine...

  • Diabetes Type II, a new perspective. Oberleas, D. // Trace Elements & Electrolytes;2011 1st Quarter, Vol. 28 Issue 1, p52 

    Abstract. Evidence exists that chromium3+ is required as a cofactor for normal insulin function. People with Type II diabetes usually synthesize ample insulin but the insulin is not effectively utilized. Insulin must form a stable union with insulin receptors at least for brief periods in the...

  • Increased beta-cell proliferation and reduced mass before diabetes onset in the nonobese diabetic mouse. Sreenan, Seamus; Pick, Anthony J.; Levisetti, Matteo; Baldwin, Aaron C.; Pugh, William; Polonsky, Kenneth S.; Sreenan, S; Pick, A J; Levisetti, M; Baldwin, A C; Pugh, W; Polonsky, K S // Diabetes;May99, Vol. 48 Issue 5, p989 

    To determine whether loss of beta-cell mass and function in the NOD mouse occurs gradually, beginning after the onset of insulitis, or abruptly, just before the onset of overt diabetes, beta-cell mass and rates of beta-cell proliferation and insulin secretory responses from the perfused pancreas...

  • Citations and Clinicians' Notes: Insulin Secretion.  // Current Medical Literature: Diabetes;2003, Vol. 20 Issue 4, p103 

    Presents citations and clinicians' notes on insulin secretion in diabetes. Beneficial effects of insulin on insulin secretion and metabolic control in type 2 diabetic patients; Influence of rosiglitazone treatment on beta-cell function in type 2 diabetes.

  • Functional Connectivity in Islets of Langerhans from Mouse Pancreas Tissue Slices. Stožer, Andraž; Gosak, Marko; Dolenšek, Jurij; Perc, Matjaž; Marhl, Marko; Rupnik, Marjan Slak; Korošak, Dean // PLoS Computational Biology;Feb2013, Vol. 9 Issue 2, Special section p1 

    We propose a network representation of electrically coupled beta cells in islets of Langerhans. Beta cells are functionally connected on the basis of correlations between calcium dynamics of individual cells, obtained by means of confocal laser-scanning calcium imaging in islets from acute mouse...

  • β cell replication is the primary mechanism for maintaining postnatal β cell mass. Georgia, Senta; Bhushan, Anil // Journal of Clinical Investigation;Oct2004, Vol. 114 Issue 7, p963 

    The endocrine pancreas undergoes major remodeling during neonatal development when replication of differentiated β cells is the major mechanism by which β cell mass is regulated. The molecular mechanisms that govern the replication of terminally differentiated β cells are unclear. We...

  • Large Islets, Beta-Cell Proliferation, and a Glucokinase Mutation.  // New England Journal of Medicine;11/25/2010, Vol. 363 Issue 22, p2178 

    Corrections to the article "Large Islets, Beta-Cell Proliferation, and a Glucokinase Mutation" in the April 8, 2010 issue are presented.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics